ALLELE DIAGNOSTICS INC
Spokane, WA · Medtech · Private
Custom-designed whole genome chromosomal microarray (CMA) assay for rapid genetic diagnosis of congenital heart defects
allelediagnostics.com →- Grants
- $3.4M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $84K
- 1 award · Defense
- #537 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Rapid Array Diagnosis of Congenital Heart Defects (RAD4CHD) Using Allele Diagnostics Rapid Array Chromosomal Microarray Strategy | $222,840 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Array Diagnosis of Congenital Heart Defects (RAD4CHD) Using Allele Diagnostics Rapid Array Chromosomal Microarray Strategy | $222,840 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Phase II: Rapid Array Diagnosis of Congenital Heart Defects (RAD4CHD) Using Allele Diagnostics Rapid Array Chromosomal Microarray Strategy | $708,996 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Phase II: Rapid Array Diagnosis of Congenital Heart Defects (RAD4CHD) Using Allele Diagnostics Rapid Array Chromosomal Microarray Strategy | $1,477,560 | |
| Federal grant | Department of Health and Human Services · Phase II · Phase II: Rapid Array Diagnosis of Congenital Heart Defects (RAD4CHD) Using Allele Diagnostics Rapid Array Chromosomal Microarray Strategy | $768,564 | |
| Federal contract | Department of Defense · Rapid Microarray Testing Service | $84,000 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 534 | ZRT LABORATORY, LLC | $92K | — |
| 535 | SYNTERMED INCORPORATED | $88K | — |
| 536 | BIOSENSE TECHNOLOGIES, INC. | $86K | — |
| 537 | ALLELE DIAGNOSTICS INC | $84K | — |
| 538 | Caption Health | $81K | $69M |
| 539 | Cleerly, Inc. | $80K | $266M |
| 540 | OMEGAQUANT ANALYTICS, LLC | $79K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.